What is 006280.KS's gross margin?

Track GC Biopharma (006280.KS) gross margin, net margin, and operating margin over time.

What is 006280.KS's P/E ratio?

Track GC Biopharma (006280.KS) P/E ratio, ROE, and valuation metrics over time.

Where can I see 006280.KS's full financials?

See GC Biopharma (006280.KS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

GC Biopharma (006280.KS) Financials — Revenue, Earnings, Cash Flow

₩125,800.00 ($93.62)

-3500.00 (-2.71%)

Weekly Expected Move ±3.9%

₩115884 ₩120842 ₩125800 ₩130758 ₩135716

KSC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · ₩1.44T mcap · 5M float · 0.970% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

₩1,964B

Revenue

+9.7% YoY

₩-49,901M

Net Income

-167.8% YoY

₩73B

Free Cash Flow

+183.1% YoY

26.0%

Gross Margin

0.4%

Op. Margin

0.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-4.0%

ROA-1.7%

ROIC1.7%

Valuation

P/E-28.8

P/B0.7

EV/EBITDA11.8

Leverage

Debt/Equity0.76

Current Ratio1.35

Interest Cov.1.1x

Quality Scores

Piotroski F6/9

Altman Z1.21

Beneish M-2.93